Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Sep 26, 2014; 6(9): 985-992
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.985
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.985
Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?
Shan Zhou, Ian Welsby, Department of Anesthesiology, Duke University Medical Center 3094, Durham, NC 27710, United States
Shan Zhou, Department of Anesthesiology, Fuwai Cardiovascular Hospital, Chinese Academy of Medical Science, Peking Union Medical School, Beijing 100037, China
Author contributions: Zhou S and Welsby I contributed to this paper.
Correspondence to: Dr. Ian Welsby, Department of Anesthesiology, Duke University Medical Center 3094, 2301 Erwin Road, Durham, NC 27710, United States. ian.welsby@dm.duke.edu
Telephone: +1-91-96682699 Fax: +1-91-92872720
Received: March 15, 2014
Revised: April 29, 2014
Accepted: July 12, 2014
Published online: September 26, 2014
Processing time: 196 Days and 22.4 Hours
Revised: April 29, 2014
Accepted: July 12, 2014
Published online: September 26, 2014
Processing time: 196 Days and 22.4 Hours
Core Tip
Core tip: In this review, we updated the reports regarding the associations between ABO blood groups and venous thrombosis, ischemic heart disease as well as postoperative outcomes after cardiac surgery. ABO blood group is clearly associated with venous thromboembolism whereas critical review of the literature reveals a more controversial relationship with atherosclerosis, arterial thrombosis and postoperative outcomes.